Kadimastem, the developer of the experimental amyotrophic lateral sclerosis (ALS) therapy AstroRx, is merging with NLS ...

Mitochondrial genome mutations may be linked to ALS, per a study, opening the door for new ways to diagnosing and treating ...

Trace Neuroscience launched on Tuesday to announce that it is developing a genetic treatment targeting UNC13A, a gene linked ...

Three years ago, longtime stage actor Aaron Lazar was diagnosed with ALS, a degenerative disease that affects nerve cells ...

including amyotrophic lateral sclerosis (ALS) and multiple sclerosis (MS), today announced its third quarter 2024 financial results and provided recent updates on its CNM-Au8 programs. Third Quarter ...

The neurological disorders institute said ALS is a progressive disease, meaning the symptoms worsen over time. April and Bill Kerner said the news was a shock to both of them. MORE: Woman with ALS ...

"If approved, NP001 would be the first immunotherapy for ALS, and the first ALS treatment shown to preserve lung function," Matthew W. Davis, MD, chief medical officer of Neuvivo, told Fox News ...

As leadership changes at the county level, Swansboro commissioners are moving forward with a plan to establish their own Advance Life Support at the Paramedic Level.

For me I can wake up and be like, all right, I feel fine today. Mentally, I feel good, so let's roll. But I think it's got to be way harder watching it." This woman has ALS.So did 22 of her relatives.

In a report released on November 4, Jakob Cakarnis from Jarden maintained a Buy rating on ALS Ltd. (CPBLF – Research Report), with a ...

BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, ...